Previous 10 | Next 10 |
THE WOODLANDS, Texas, July 28, 2022 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) (“ Lexicon ”) today announced the pricing of its previously announced underwritten public offering of 16,843,600 shares of its common stock, par value $0.001 (the ...
Lexicon Pharmaceuticals ( NASDAQ: LXRX ) shares dipped 16% in extended session after the biopharmaceutical company proposed an underwritten public offering of common stock. Lexicon intends to grant the underwriters a 30-day option to purchase additional shares of the s...
THE WOODLANDS, Texas, July 27, 2022 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) (“ Lexicon ”) today announced that it has commenced an underwritten public offering to offer and sell, subject to market and other conditions, shares of its common stoc...
Clinical-stage biotech Lexicon Pharmaceuticals ( NASDAQ: LXRX ) announced on Wednesday that the FDA accepted its New Drug Application (NDA) for sotagliflozin, an experimental therapy targeted at heart failure. The regulator has granted a standard review for the NDA with a PDUF...
THE WOODLANDS, Texas, July 27, 2022 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review and filed its New Drug Application (NDA) for sotagliflozin, an investigational dual SGLT1 and SGL...
Lexicon's Phase II proof-of-concept study in diabetic neuropathy delivered some encouraging signs of efficacy, but more data and potentially further dose optimization work are needed. Pain is a significant commercial opportunity for Lexicon, but it will likely need a partner to maximi...
Gainers: Rubicon Technology ( RBCN ) +68% . Faraday Future Intelligent Electric ( FFIE ) +65% . Ra Medical Systems ( RMED ) +61% . Xilio Therapeutics ( XLO ) +35% . Maris-Tech ( MTEK ) +35% . Lexicon Pharmaceuticals ( LXRX ...
Perimeter Solutions ( PRM ) +38% . Compute Health Acquisition ( CPUH ) +12% . Cano Health ( CANO ) +12% . Lexicon Pharmaceuticals ( LXRX ) +6% . Pure Storage ( PSTG ) +6% . For further details see: PSTG, LXRX and CANO a...
Renalytix ( RNLX ) -28% on Q3 earnings release . Angion Biomedica ( ANGN ) -27% after it discontinued phase 2 trial of ANG-3070 in patients with kidney disease . Exicure ( XCUR ) -23% as it implements reverse-stock-split to get back Nasdaq com...
Gainers: Adagene ( ADAG ) +20.3 % . Qorvo ( QRVO ) +11.5% . Lexicon Pharmaceuticals ( LXRX ) +9.8% . Avadel Pharmaceuticals ( AVDL ) +9.0% . The RealReal ( REAL ) +7.3% . Losers: HyperFeed Technologies ( HYPR ) ...
News, Short Squeeze, Breakout and More Instantly...
Lexicon Pharmaceuticals Inc. Company Name:
LXRX Stock Symbol:
NASDAQ Market:
Lexicon Pharmaceuticals Inc. Website:
THE WOODLANDS, Texas, July 25, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) will release its second quarter 2024 financial results on Thursday, August 1, 2024 after the markets close. Management will conduct a conference call and live webcast at 5:00 p.m. ET (4:00...
Launch Preparations Actively Underway; Launch Planned for Early 2025 Lexicon Seeks Approval for Zynquista™ (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease THE WOODLANDS, Texas, July 16, 20...
New analysis of the pivotal Phase 3 SOLOIST-WHF trial provides additional evidence of positive economic impact on hospitals participating in various alternative payment models (APM) Findings consistent with two peer-reviewed studies published in June 2024 THE WOODLANDS, Texa...